Recent Headlines
Americans’s interest in a COVID-19 vaccine is waning, with only 56% of adults saying they would get it if it were available. That’s down from 74% in April.
-
The U.K. has approved a second COVID-19 vaccine. AstraZeneca says it aims to supply millions of doses in the first quarter.
-
The rate of new coronavirus cases among residents of Vietnamese and Filipino descent is rising faster than among other Asian groups in Santa Clara County, officials say.
-
Health experts hope to nudge people of color to the front of the COVID-19 vaccine line without explicitly saying race, ethnicity influence priority.
The coronavirus variant is found in a man in his 20s who is in isolation southeast of Denver and has no travel history, state health officials say.
The first U.S. government dietary guidelines for infants and toddlers recommend breast milk only for at least six months and no added sugar for kids under 2.
The extension illustrates how the worst wave of the pandemic is hammering hospitals in Southern California and the San Joaquin Valley and threatening to exhaust available intensive care beds.
The COVID-19 pandemic has revived the autopsy at many hospitals. The procedure has helped doctors understand what the coronavirus does to patients’ organs.
The World Health Organization urges more genomic sequencing to ensure new variants of the coronavirus are detected as pandemic enters its second year.
Children are more at risk of contracting the coronavirus at a social gathering than at school, according to a Mississippi study published by the CDC.
A huge study of another COVID-19 vaccine candidate is getting underway in the U.S. This one is made by Novavax.
World events influence language, and words once reserved for science or academia — think “social distancing” and “pandemic” — are used all over.
Health news, ideas, advice and commentary.
Most Read
-
If the COVID-19 vaccine from Pfizer and BioNTech was good enough to get a nod from the FDA, the vaccine from Moderna and the NIH almost certainly is as well.
-
Can you have Thanksgiving during the COVID-19 pandemic? Researchers have created an interactive map that estimates the risk you’ll face in any county.
-
Americans’s interest in a COVID-19 vaccine is waning, with only 56% of adults saying they would get it if it were available. That’s down from 74% in April.
Drugmaker AstraZeneca says its developmental COVID-19 vaccine ‘should remain effective’ against the new coronavirus strain spreading through Britain.
L.A. County is testing to see whether a potentially more contagious coronavirus strain is in the community. Mayor Eric Garcetti says it appears likely.
An intensive care nurse in Mexico City has become the first person in Latin America to receive an approved COVID-19 vaccine.
Africa’s top public health official says another new coronavirus variant appears to have emerged in Nigeria, but further investigation is needed.
L.A. County’s explosion of COVID-19 hospitalization is literally off the charts, forcing officials to draw new ones.
Gov. Newsom says he’s been discussing new protocols with airlines and others to keep a new, more contagious strain of coronavirus out of California.
BioNTech’s chief is confident the COVID-19 vaccine his company developed with Pfizer will work against the new coronavirus strain hitting Britain.
The increase over 2019’s total fatalities will mark the largest single-year percentage leap since 1918.
U.S. infectious disease experts underestimated the fast-moving coronavirus outbreak in its early days, assuming the country would emerge largely unscathed.
Covid-19 Vaccines
The CDC said 11.45 million vaccine doses had been distributed but only 2.13 million people had gotten shots, as local health agencies struggle.
-
Doubts about the vaccine among healthcare workers could have serious implications for public health, say experts.
-
Taxpayers financed COVID-19 vaccine research. Now companies want to profit, leaving poor countries in a bind.
-
Gov. Gavin Newsom said he’s serious about cracking down on medical providers who divert COVID-19 vaccines to non-priority patients or sell them on the black market. Good.
-
No one should listen to ‘yoga moms’ spouting nonsense on COVID-19 vaccines instead of scientists and doctors.
-
Frontline workers and long-term workers are supposed to be first in line to receive the COVID-19 vaccine, but there are exceptions.
More Coverage
More headlines
-
The question of how many people must be vaccinated to reach herd immunity against COVID-19 is of crucial importance. Experts say the number is probably higher than previously thought.
-
Jupiter and Saturn should be easily visible around the world a little after sunset, weather permitting.
-
South Africa says a new variant of the coronavirus, different from one in Britain, is driving a resurgence of infections, hospitalizations and deaths.
-
Compared with the testing of COVID-19 vaccines and drugs, few randomized trials exist on the effects of transmission-prevention efforts.
-
British scientists have found a version of the coronavirus with a cluster of genetic changes that make it more transmissible and perhaps more dangerous.
-
Vaccine hesitancy has a long history in the United States. Here are three ways to help break through vaccine fears.
-
Skepticism about the newly authorized coronavirus vaccines pervades Native American communities even as the death toll mounts.
-
Americans waiting their turn for a COVID-19 vaccine may not be pleased to see who’s in line ahead of them. Does a prisoner or smoker deserve it more?
-
The Food and Drug Administration grants emergency-use authorization to the COVID-19 vaccine from Moderna and the National Institutes of Health.
-
A new study says a little love from underlings can ‘positively impact supervisors’ attitudes, well-being and behavior.’ In case you were wondering.
-
Sewage data analyzed in Silicon Valley wastewater treatment plants confirms that the latest wave of coronavirus infections is sharply worse than the ones in the spring and summer.
Get our free Coronavirus Today newsletter
Sign up for the latest news, best stories and what they mean for you, plus answers to your questions.
You may occasionally receive promotional content from the Los Angeles Times.
